Richmond, VA—AIBioTech has received a clinical laboratory permit from the Clinical Laboratory Evaluation Program (CLEP) of the New York State Department of Health to perform clinical testing on samples collected in the state. This includes its comprehensive pharmacogenetic testing panel.
AIBioTech’s pharmacogenetic panel can provide vital information to physicians to determine the therapeutic value of commonly used drugs for managing cardiovascular conditions, psychiatric conditions and pain.
Other clinical tests that AIBioTech™ is certified to provide by CLEP include an in vitro diagnostic test for cystic fibrosis.
AIBioTech is a comprehensive contract research organization which provides clinical testing and research and development services to physicians; biotechnology and pharmaceutical companies; academic institutions, and several different government agencies. It also operates a forensics and paternity testing division under the name Fairfax Identity Laboratories. For more information about its capabilities and services visit the company website at www.aibiotech.com.